Norges Bank Neogenomics Inc Transaction History

Norges Bank

  • $736 Billion
  • Q4 2024

A detailed history of Norges Bank transactions in Neogenomics Inc stock. As of the latest transaction made, Norges Bank holds 380,664 shares of NEO stock, worth $4.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
380,664
Holding current value
$4.23 Million
% of portfolio
0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$13.0 - $18.43 $4.95 Million - $7.02 Million
380,664 New
380,664 $6.27 Million
Q2 2024

Aug 14, 2024
BUY
$13.01 - $15.77 $7.89 Million - $9.56 Million
606,341 New
606,341 $8.41 Million
Q4 2023

Feb 09, 2024
BUY
$11.67 - $20.73 $10.5 Million - $18.6 Million
896,885 New
896,885 $14.5 Million
Q3 2023

Nov 13, 2024
BUY
$12.15 - $17.85 $11.6 Million - $17.1 Million
956,905 New
956,905 $11.8 Million
Q3 2023

Nov 13, 2023
SELL
$12.15 - $17.85 $14.4 Million - $21.2 Million
-1,186,214 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$14.1 - $19.83 $7.32 Million - $10.3 Million
519,208 Added 85.63%
1,125,549 $18.1 Million
Q2 2023

Aug 14, 2023
SELL
$14.1 - $19.83 $15 Million - $21.1 Million
-1,066,297 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$9.09 - $19.45 $10.4 Million - $22.3 Million
1,146,221 New
1,146,221 $20 Million
Q4 2022

Feb 14, 2023
BUY
$6.45 - $12.07 $9.14 Million - $17.1 Million
1,416,714 New
1,416,714 $13.1 Million
Q3 2022

Nov 13, 2023
BUY
$7.86 - $12.91 $9.32 Million - $15.3 Million
1,186,214 New
1,186,214 $10.2 Million
Q2 2022

Aug 14, 2023
BUY
$7.06 - $13.97 $7.53 Million - $14.9 Million
1,066,297 New
1,066,297 $8.69 Million
Q1 2022

May 12, 2023
SELL
$12.15 - $35.28 $7.26 Million - $21.1 Million
-597,379 Reduced 42.17%
819,335 $9.95 Million
Q1 2022

May 09, 2022
SELL
$12.15 - $35.28 $9.95 Million - $28.9 Million
-819,335 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$30.49 - $48.49 $25 Million - $39.7 Million
819,335 New
819,335 $28 Million
Q3 2021

Nov 14, 2022
BUY
$41.66 - $52.52 $32 Million - $40.4 Million
768,878 New
768,878 $37.1 Million
Q3 2021

Nov 05, 2021
SELL
$41.66 - $52.52 $33.7 Million - $42.5 Million
-809,280 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$36.62 - $51.69 $29.6 Million - $41.8 Million
809,280 New
809,280 $36.6 Million
Q2 2021

Aug 10, 2021
SELL
$36.62 - $51.69 $33.4 Million - $47.1 Million
-911,813 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$41.56 - $59.88 $37.9 Million - $54.6 Million
911,813 New
911,813 $44 Million
Q1 2021

May 07, 2021
SELL
$41.56 - $59.88 $39.2 Million - $56.5 Million
-943,690 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$36.08 - $56.47 $34 Million - $53.3 Million
943,690 New
943,690 $50.8 Million
Q4 2020

Feb 10, 2021
SELL
$36.08 - $56.47 $31.5 Million - $49.3 Million
-873,626 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$33.26 - $40.48 $29.1 Million - $35.4 Million
873,626 New
873,626 $32.2 Million
Q3 2020

Nov 10, 2020
SELL
$33.26 - $40.48 $28 Million - $34 Million
-841,140 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$24.21 - $31.02 $20.4 Million - $26.1 Million
841,140 New
841,140 $26.1 Million
Q2 2020

Aug 07, 2020
SELL
$24.21 - $31.02 $21.3 Million - $27.3 Million
-879,259 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$20.5 - $34.53 $18 Million - $30.4 Million
879,259 New
879,259 $24.3 Million
Q1 2020

May 08, 2020
SELL
$20.5 - $34.53 $17.3 Million - $29.1 Million
-844,190 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$18.96 - $29.84 $16 Million - $25.2 Million
844,190 New
844,190 $24.7 Million
Q4 2019

Feb 12, 2020
SELL
$18.96 - $29.84 $5.97 Million - $9.4 Million
-314,974 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$19.12 - $26.24 $6.02 Million - $8.26 Million
314,974 New
314,974 $6.02 Million

Others Institutions Holding NEO

# of Institutions
282
Shares Held
124M
Call Options Held
751K
Put Options Held
107K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.4B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email